Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.786
Neutral
RSI(14)
54.470
Neutral
STOCH(KDJ)(9,3,3)
47.062
Neutral
ATR(14)
2.619
Low Volatility
CCI(14)
54.866
Neutral
Williams %R
32.035
Buy
TRIX(12,20)
0.028
Sell
StochRSI(14)
100.000
Buy
Abbott Laboratories
ABTView Detailed Chart
131.750USD
+2.470+1.91%
Close 08/15, 16:00（ET）Quotes delayed by 15 min
229.31BMarket Cap
16.98P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.91%
5 Days
-1.88%
1 Month
+0.20%
6 Months
+0.87%
Year to Date
+16.48%
1 Year
+18.76%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
31
analysts
BUY
Current Rating
141.510
Target Price
9.46%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
7
Median
8
Average
Company name
Ratings
Analysts
Abbott Laboratories
ABT
31
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
28
Insulet Corp
PODD
26
1
2
3
...
24
Abbott Laboratories Trading Strategy
Short Term
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Buy
Moving Average
Indicators
Value
Direction
MA5
130.562
Buy
MA10
131.070
Buy
MA20
128.762
Buy
MA50
131.446
Buy
MA100
131.081
Buy
MA200
126.480
Buy
News
Abbott beats quarterly profit estimates on medical devices demand
July 17 (Reuters) - Abbott ABT.N beat Wall Street estimates for quarterly profit on Thursday, driven by strong demand for its medical devices including continuous glucose monitors.
ReutersThu, Jul 17
Trump Plans Major Drug Price Cuts, Pharma Stocks Tumbles
Trump signals an executive order to slash drug prices, causing a sharp sell-off in Asian pharmaceutical stocks. Major companies like Johnson & Johnson, Pfizer, and Abbott could be hit hard.
TradingKeyMon, May 12
.jpg)
How Artificial Intelligence Benefits Health Care: 10 AI Healthcare Stocks to Watch
TradingKey - With the rapid development of artificial intelligence (AI), beyond the well-known large language models such as ChatGPT and DeepSeek, people are continuously exploring new AI applications and investigating how the cutting-edge technologies driving the "Fourth Industrial Revolution"...
TradingKeyWed, Mar 12
Abbott Laboratories falls on Q1 profit forecast below estimates
Shares of medical device maker Abbott Laboratories ABT.N fall 2.02% to $114.43 premarket.Co expects Q1 adj EPS of between $1.05 and $1.09, below estimates of $1.11 - data compiled by LSEG. Forecasts 2025 adj EPS of $5.05 to $5.25, with midpoint mostly in line with estimates of $5.16...
ReutersWed, Jan 22
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Abbott Laboratories is an American multinational health care and medical devices corporation headquartered in Abbott Park, Illinois. Founded in 1888 by Chicago physician Wallace Calvin Abbott, the company initially focused on formulating known drugs. Today, it offers medical devices, diagnostics, branded generic medications, and nutritional products. In 2013, Abbott separated its research-based pharmaceuticals division into AbbVie.
Abbott's product lineup includes Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.
Ticker SymbolABT
CompanyAbbott Laboratories
CEOMr. Robert B. Ford
Websitehttps://www.abbott.com
Related Instruments
+0.90%
+1.13%
-0.70%
+0.48%
-0.48%
+1.06%
+1.24%
-0.24%
+1.74%
+0.62%
0.00%
-1.15%
-0.25%
-1.10%
-2.43%
-0.31%
-0.08%
+1.32%
-0.10%
+0.92%
